Natus Medical announce share repurchase program Natus Medical announced that its board has approved a stock repurchase program authorizing the repurchase of up to $10M of the company's common stock. There is no set expiration date for the program. The primary objective of the share repurchase program is to offset the impact of dilution from issuances relating to employee equity grants and the company's employee stock purchase program. The company intends to use cash on hand, cash generated from operations, existing credit facilities or other financing to fund the share repurchase program. As of March 31, the company had cash and cash equivalents of approximately $60M and availability under an existing line of credit of $25M.